NRXP (NRx Pharmaceuticals Inc.) רווח נקי למניה אחת בשנים עשר החודשים האחרונים

The current share price of NRx Pharmaceuticals (NRXP) shown on this chart allows for an assessment of the success in developing treatments for suicidal states, where the key factor is regulatory approval of the NRX-101 therapy. The model is based on outsourcing production and testing, which minimizes capital expenditures. However, high R&D expenses keep the operating leverage negative, with the indicator standing at 78.40.
NRXP (NRx Pharmaceuticals, Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים

For the innovative psychotherapeutic developer NRx Pharmaceuticals (NRXP), this metric serves as an indicator of how clinical success translates into actual earnings per share. By analyzing the annual percentage growth of EPS TTM, an investor assesses the net income dynamics over a rolling year, which allows for the diagnosis of fundamental business stability and the timely identification of asset overvaluation risks at extreme metric values.